Wave Life Sciences Ltd (NASDAQ:WVE) – Experts See The Stock A Different Way Today

In the last trading session, 2.79 million shares of the Wave Life Sciences Ltd (NASDAQ:WVE) were traded, and its beta was -0.97. Most recently the company’s share price was $6.41, and it changed around -$1.32 or -17.08% from the last close, which brings the market valuation of the company to $987.71M. WVE currently trades at a discount to its 52-week high of $16.74, offering almost -161.15% off that amount. The share price’s 52-week low was $4.25, which indicates that the current value has risen by an impressive 33.7% since then.

Wave Life Sciences Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.15. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended WVE as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight.

Wave Life Sciences Ltd (NASDAQ:WVE) trade information

Instantly WVE has showed a red trend with a performance of -17.08% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 8.39 on recent trading dayincreased the stock’s daily price by 23.6%. The company’s shares are currently down -48.18% year-to-date, but still down -12.67% over the last five days. On the other hand, Wave Life Sciences Ltd (NASDAQ:WVE) is 6.30% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $36, which translates to bulls needing to increase their stock price by 82.19% from its current value. Analyst projections state that WVE is forecast to be at a low of $36 and a high of $36.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 34.27%. Wave Life Sciences Ltd earnings are expected to increase by -39.23% in 2025, but the outlook is negative -1.30% per year for the next five years.

WVE Dividends

Wave Life Sciences Ltd’s next quarterly earnings report is expected to be released in June.

MAVERICK CAPITAL LTD, with 5.9211% or 7.67 million shares worth $38.27 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

iShares Trust-iShares Russell 2000 ETF and PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 2.53 shares worth $16.21 million, making up 1.64% of all outstanding shares. On the other hand, PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund held roughly 2.44 shares worth around $15.64 million, which represents about 1.58% of the total shares outstanding.